Top Back to top

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Severe Aplastic Anaemia Working Party (SAAWP)
Study type:
Study number:
8409077
Type of Stem Cell Treatment:
 
Diseases:
Bone marrow failure
Short title:
ATG in aPRCA
Primary objective:
To investigate the effectivity of treatment with ATG in patients with acquired PRCA.
Key inclusion criteria:
Patients are eligible if:
1) they have been diagnosed with acquired PRCA and
2) received ATG treatment between 2000 and 2018.
Country:
 
Principal investigator:
Stijn Halkes
EBMT Study coordinator:
Brian Piepenbroek
Study coordinator email:
saawpebmt@lumc.nl